ArticleAntimicrobial agents and chemotherapy2019
Characterization of
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Epidemiology, genetic dynamics, and transmission of theEmerging microbes & infections · 2025Article
- The Etiology and Antimicrobial Susceptibility of Community-Onset Urinary Tract Infections in a Low-Resource/High-Resistance Area of Latin America.Tropical medicine and infectious disease · 2025Article
- Detection and Characterisation of Colistin-ResistantMicroorganisms · 2024Article
- Plasmid-mediated colistin resistance from fresh meat and slaughtered animals in the Czech Republic: nation-wide surveillance 2020-2021.Microbiology spectrum · 2023Article
- Article
- The occurrence and molecular detection ofFrontiers in microbiology · 2023Article
- Plasmid-mediated colistin resistance among human clinicalFrontiers in microbiology · 2023Article
- Occurrence and Characterisation of Colistin-ResistantMicroorganisms · 2022Article
- Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistantEFSA journal. European Food Safety Authority · 2022Article
- Colistin Resistance Mechanisms in HumanAntibiotics (Basel, Switzerland) · 2022Article
- Global epidemiology, genetic environment, risk factors and therapeutic prospects ofFrontiers in cellular and infection microbiology · 2022Review
- Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility ofPharmaceutics · 2021Article
- Genomic Characterization of Antimicrobial Resistance in Food Chain and Livestock-AssociatedAnimals : an open access journal from MDPI · 2021Review
- Whole-Genome Sequencing of Gram-Negative Bacteria Isolated From Bovine Mastitis and Raw Milk: The First Emergence of ColistinFrontiers in microbiology · 2021Article
- The Spatiotemporal Dynamics and Microevolution Events That Favored the Success of the Highly Clonal Multidrug-Resistant MonophasicFrontiers in microbiology · 2021Article
- Molecular Characterization and Survive Abilities ofFrontiers in microbiology · 2021Article
- Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance.Membranes · 2020Review
- Development of a NovelFrontiers in microbiology · 2020Article
- Plasmid Dynamics ofFrontiers in microbiology · 2020Article
- A Multidrug-resistant MonophasicInfection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We characterized eight
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.